Mark Burdon is an independent community pharmacy contractor and chairman of the Pharmaceutical Services Negotiating Committee’s resource development and finance subcommittee.
Generic shortages: what can be done?Subscription
The supply of generic medicines is vulnerable to the vicissitudes of market forces, with exchange rates fluctuating and manufacturers restricting distribution. The Department of Health needs to intervene to shield pharmacies from the impact of price spikes and ensure the resilience of the supply chain.
Tribute to Maurice Peston Subscription
I was never fortunate enough to meet Maurice Peston, but his legacy is remarkable and fascinating. During my research I have spoken to a number of people associated with our profession who knew and worked closely with Maurice, but I am still unclear exactly how his association with pharmacy began. The most plausible explanation is that during the commissioning of the inveterate Nuffield report in the early 1980s, a distinguished economist was sought. That guru was Maurice Peston, a mac
‘Debranding’ of branded productsSubscription
For some years now, certain manufacturers have been removing the brand name of a medicine and relaunching the product as a generic — so called “debranding”. The aim of this exercise is to circumvent the Pharmaceutical Price Regulation Scheme (PPRS) and allow the manufacturer to increase the price to the NHS. As well as the additional cost to the NHS that this practice causes, it also has potential to affect patient safety. One such example is primidone tablets. The originator brand, My